About this work

Purpose
Capture which serum tumour markers are requested and why — clinical indication, relevant history, known cancer site, and prior marker value — and produce a vetting report the laboratory and requesting team can triage from, supporting a decision to accept, query, redirect, or reject the request. Tumour markers are poor screening tests, so the form discourages non-evidence-based screening.
Specification
Spec-driven: the living domain spec defines the data model, the four-axis grading engine, and the safety-critical flag rules. The same engine grades both the form and the dashboard.
Documentation
Aligned with NICE CG122 / NG12 (CA125 / suspected cancer), NICE NG131 / NHS PSA guidance, and ACB / RCPath tumour-marker recommendations.